Inotrem
Paris, France· Est.
Develops immunotherapies targeting the TREM-1 pathway for inflammatory and infectious diseases.
Private Company
Total funding raised: $105M
About
Develops immunotherapies targeting the TREM-1 pathway for inflammatory and infectious diseases.
RNA & Gene Therapy
Funding History
3Total raised:$105M
Series C$60M
Series B$35M
Series A$10M